- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Marijuana for Trauma Files Lawsuite Against OrganiGram
Marijuana for Trauma Inc. announced that is has begun a lawsuit against OrganiGram Holdings Inc. (TSXV:OGI), whose wholly owned subsidiary OrganiGram Inc. is a licensed medical marijuana producer in Canada.
Marijuana for Trauma Inc. announced that is has begun a lawsuit against OrganiGram Holdings Inc. (TSXV:OGI), whose wholly owned subsidiary OrganiGram Inc. is a licensed medical marijuana producer in Canada.
As quoted in the press release:
The lawsuit was filed with the Court of Queen’s Bench of New Brunswick, Judicial District of Fredericton for: breach of confidence, conversion, breach of contract, conspiracy and breach of trust, breach of fiduciary duty, and negligent misrepresentation.
The lawsuit alleges OrganiGram denied MFT its interest in Trauma Healing Centers Inc. (THC). THC, developed through a partnership between MFT, OrganiGram and Denis Arsenault, CEO of OrganiGram and also a Defendant in the lawsuit, opened centres in several cities in eastern Canada to provide services to those suffering from post-traumatic stress disorder (PTSD) and other chronic conditions caused by trauma. MFT alleges that OrganiGram unlawfully terminated the relationship, unlawfully used MFT’s proprietary information, business practices, and expansion plans for MFT. Following the termination of the relationship in February 2015, THC moved to restrict MFT from helping veterans and first responders outside of New Brunswick.
Fabian Henry, president of Marijuana for Trauma, commented:
We had an agreement with OrganiGram and Denis Arsenault to expand our services assisting veterans suffering from PTSD. The agreement was supposed to create a seamless experience for approved clients in need of a referral to a licensed medical marijuana producer. The termination of our business arrangement and subsequent use of our business and expansion plans is unlawful and will affect our ability to help hundreds of veterans.
Click here to read the full Marijuana for Trauma press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.